Alembic Pharma forms JV with Orbicular for derma products.
Alembic Pharmaceuticals Ltd (APL) has formed a 60:40 joint venture (JV) with the Hyderabad-based Orbicular Pharmaceutical Technologies Pvt Ltd to... Full Story
Browse All News by Date
Rusan Pharma aims to double turnover to Rs 600 cr by 2018
With a focus on research and development (R&D), Rusan Pharma, which specialises in pain management, opioid de-addiction & anti-infectives therapies,... Full Story
More Top Stories
This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2021